Canadian Cancer Trials Group Bulletins


Brain Site Committee

Since 1996, the Canadian Cancer Trials Group has been privileged to have Dr. Greg Cairncross as the Chair of the Brain Site Committee. Under Dr. Cairncross's leadership, the Brain Committee has evolved from a small group of investigators completing Investigational New Drug studies to a full fledged Scientific Disease Site Committee that is leading and participating in important international phase III trials. The results of these trials have been practice-changing and widely cited. We are very grateful for the energy and leadership that Dr. Cairncross has provided and are fortunate that he will remain a contributing member of the Brain Committee Executive.

As of February 2009, Dr. Cairncross will be stepping down from this position. We are, however, very pleased to indicate that Dr. Warren Mason will continue in his current role as Co-chair of the Committee, only now this role will be that of Committee Chair. Under the leadership of Dr. Mason, the Brain Disease Site will build on its record, its collaboration with international partners and the development of new strategies of investigation.